Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
3
4
5
6
7
8
9
10
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
1
2
3
4
iHealth 2017 Clinical Informatics Conference
2017-05-02 - 2017-05-04    
All Day
iHealth 2017 Clinical Informatics Conference May 02 - 04, 2017 Philadelphia, PA Loews Philadelphia Hotel Register Now About the ConferenceiHealth is where clinicians, informatics professionals [...]
Chicago Health IT Summit
2017-05-11 - 2017-05-12    
All Day
About the Health IT Summits Renowned leaders in U.S. and North American healthcare gather throughout the year to present important information and share insights at [...]
Events on 2017-05-02
Events on 2017-05-11
Chicago Health IT Summit
11 May 17
Chicago
Latest News

Emerson Electric Co. (NYSE: EMR) – worth at $111?

Emerson Electric Co. (NYSE: EMR) is under scrutiny today. Its stock has surged by 24% in recent months on the NYSE, nearing its 52-week peak. This indicates that any shifts in the company’s prospects may already be reflected in its stock price. Yet, is there still room for a good deal? Let’s delve into Emerson Electric’s valuation and future outlook to gauge potential bargain opportunities.

Assessing Emerson Electric’s Value
Our valuation model suggests the stock is currently reasonably priced, sitting approximately 8.2% below its intrinsic value. If you subscribe to the belief that the company’s true value stands at $121.19, there might not be much upside beyond its current price. However, the stock’s high beta suggests that in bearish markets, its price could drop more steeply than the broader market, presenting a favorable entry point.

Prospects for Growth
Looking ahead, future growth prospects are crucial, especially for investors seeking portfolio expansion. Investing in a strong company at a discounted rate is usually wise. Emerson Electric anticipates a robust 45% profit growth in the coming years, indicating potential for increased cash flow and higher stock valuation.

Implications for Investors
For current shareholders, it appears that EMR’s positive outlook is already factored into its fair value. However, other factors like the company’s financial stability warrant consideration. For potential investors, while now might not be the optimal time to buy given the fair valuation, the promising outlook suggests delving deeper into factors such as the strength of the company’s balance sheet to capitalize on future price fluctuations.